AvDesk specialists®

Dott.ssa Beatrice Ferrari

Dott.ssa Beatrice Ferrari

Dott.ssa Beatrice Ferrari

Dr. Ferrari has the Linari Medical Certification to provide AvDesk’s therapies to adults and children affected by visual field deficit.

Doc Beatrice Ferrari is a Neuropsychomotricist of the developmental age, graduated in NeuroTherapy and Psychomotricity of the Evolutionary Age at the University of Milan.
She currently works as a Neuropsychomotricist of the developmental age as a freelancer at the Centro RTP di Milano; Associazione ComuneMente di Milano and Milano Psicomotricità.

Having the Linari Therapist certification, Doc Beatrice Ferrari will help you during your first therapy, so that you can follow it both at home or in her clinic.

CONTACT US

AvDesk at home

AvDesk is a user-friendly device, transportable, and easy to install.
Just arrange it on your desk in a quiet place and your Doctor will remotely provide you a customized therapy, enabling you to undergo the treatment on your own, whenever you want.

AvDesk posizionato su un tavolino a casa
AvDesk posizionato in una camera con vista

AvDesk in clinic

You can also undergo the treatment at your doctor’s clinic.

Telehealth

Telehealth  allows the device use in the clinic without the physical presence of a doctor or his assistant. What makes that possible is the union between cloud-connected artificial intelligence technologies and doctor sensibility and experience. The Linari Medical Tutors take care of the patient on remote during the whole treatment, daily updating, and adapting the treatment protocol, based on the patient’s real brain plasticity

Information, images, descriptions and any data reported on the site concerning medical devices are not intended for promotion but as scientific material addressed exclusively to healthcare professionals. Therefore if keep surfing, the reader declares to be a Healthcare Professional. Reference: Ministry of Health – New guidelines for advertisement concerning medical devices, in vitro diagnostic and surgical medical devices of 28 March 2013; Update of the Guidelines on the use of new means of diffusion of healthcare advertising of 17 February 2010.